晚期非小细胞肺癌化疗效果与费用分析

Comparing the Costs and Effectiveness of Chemotherapy Regimens for Treating Advanced Non-small Cell Lung Cancer

目的:分析非小细胞肺癌3种化疗方案的疗效和费用的关系,控制医疗费用,以减轻病人住院经济负担。方法:回顾性调查68例晚期非小细胞肺癌采用MVP方案、NP和TP方案的疗效和平均费用。结果:MVP方案、NP方案和TP方案对于晚期非小细胞肺癌的疗效分别是28.6％、40.9％和38.8％。三者之间未见到明显差异,对于复治的病人NP方案和TP方案比MVP方案疗效高,但NP方案和TP方案之间未见明显差异。MVP方案、NP方案和TP方案平均费用分别为3487.26元、12450.21元和38499.43元。结论:3种化疗方案对于晚期非小细胞肺癌的治疗效果无明显差别,建议对于初治的晚期非小细胞肺癌病人选择MVP方案,对于复治的病人选择NP方案。

To eva luate and compare the costs and effectiveness of chemotherapy regimens for treating advanced non - small cell lung cancer. Methods: 68 patients with advanced non - small cell lung cancer were treated by 3 chemotherapy regimens. Results: The response ratse of Chemotherapy were 28. 6% in MVP regimen groups, 40. 9% in NP regimen groups, 38. 8% in TP regimen groups, no difference were found in 3 chemotherapy regimens. The costs of chemotherapy were 3487. 26 yuan in MVP regimen groups, 12 450. 21 yuan in NP regimen groups, 38 499. 43 yuan in TP regimen groups. Conclusion: The response rates were similar in 3 chemotherapy regimens. we suggest that to select MVP regimen for untreated patients, NP regimen for treated patients in clinical practise.